Stenocare - nye markeder og ny finansiering
-
Helge Larsen taler med Stenocares CEO, Thomas Skovlund Schnegelsberg, oven på q3-regskabet og vender det begivenhedsrige år for selskabet. Stenocare har udvidet deres markeder fra at være i to lande til nu at være i fem. De har fået to nye medicinske cannabis-produkter godkendt i Danmark, tre godkendt i England, tre i Norge og et i Australien. De har hentet ny finansiering.
Stenocare dyrker, importerer og sælger receptpligtig medicinsk cannabis-olie.
Disclaimer: Stenocare har betalt IR-samarbejde med ProInvestor.com.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind